ARID1A Gene Expression in High-Grade Endometrial Carcinomas

被引：0
|
作者：
Allo, G. [1 ]
Mackay, H. [1 ]
Rouzbahman, M. [1 ]
Shaw, P. [1 ]
Bernardini, M. [1 ]
Clarke, B. A. [1 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1086
引用
收藏
页码：258A / 258A
页数：1
相关论文
共 50 条
  • [1] ARID1A Gene Expression in High-Grade Endometrial Carcinomas
    Allo, G.
    Mackay, H.
    Rouzbahman, M.
    Shaw, P.
    Bernardini, M.
    Clarke, B. A.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 258A - 258A
  • [2] Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas
    Wiegand, Kimberly C.
    Lee, Anna F.
    Al-Agha, Osama M.
    Chow, Christine
    Kalloger, Steve E.
    Scott, David W.
    Steidl, Christian
    Wiseman, Sam M.
    Gascoyne, Randy D.
    Gilks, Blake
    Huntsman, David G.
    [J]. JOURNAL OF PATHOLOGY, 2011, 224 (03): : 328 - 333
  • [3] ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas
    Allo, Ghassan
    Bernardini, Marcus Q.
    Wu, Ren-Chin
    Shih, Ie-Ming
    Kalloger, Steve
    Pollett, Aaron
    Gilks, C. Blake
    Clarke, Blaise A.
    [J]. MODERN PATHOLOGY, 2014, 27 (02) : 255 - 261
  • [4] ARID1A expression in various molecular subgroups in endometrial carcinomas
    Evsei, A.
    Birceanu-Corobea, A.
    Ghita, M.
    Sajin, M.
    Copca, N.
    [J]. HISTOPATHOLOGY, 2022, 81 : 84 - 84
  • [5] Relevance of ARID1A Mutations in Endometrial Carcinomas
    De Leo, Antonio
    Ravegnini, Gloria
    Musiani, Francesco
    Maloberti, Thais
    Visani, Michela
    Sanza, Viviana
    Angelini, Sabrina
    Perrone, Anna Myriam
    De Iaco, Pierandrea
    Corradini, Angelo Gianluca
    Rosini, Francesca
    Grillini, Marco
    Santini, Donatella
    Ceccarelli, Claudio
    Zamagni, Claudio
    Tallini, Giovanni
    de Biase, Dario
    [J]. DIAGNOSTICS, 2022, 12 (03)
  • [6] Endometrial Carcinomas: Exploring the Concordance Between ARID1A Immunohistochemistry and ARID1A Mutational Status
    Storozuk, Tanner
    Wang, Peng
    Lastra, Ricardo
    Bennett, Jennifer
    [J]. LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 748 - 749
  • [7] Endometrial Carcinomas: Exploring the Concordance Between ARID1A Immunohistochemistry and ARID1A Mutational Status
    Storozuk, Tanner
    Wang, Peng
    Lastra, Ricardo
    Bennett, Jennifer
    [J]. MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 748 - 749
  • [8] Histopathologic Correlation with ARID1A Immunohistochemistry in Endometrial Carcinomas, Including Description of Subclonal ARID1A Loss
    Xiong, Jessie
    Smith, Lynelle
    Black, Margaret
    Wolsky, Rebecca
    Post, Miriam
    [J]. LABORATORY INVESTIGATION, 2024, 104 (03) : S1270 - S1271
  • [9] Correlation and Prognostic Significance of Mismatch Repair (MMR) Protein and ARID1A Gene Expression in Endometrial Carcinomas (ECs)
    Allo, G.
    Kalloger, S.
    Pollett, A.
    Bernardini, M.
    Clarke, B.
    [J]. MODERN PATHOLOGY, 2013, 26 : 264A - 264A
  • [10] ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas
    Werner, Henrica M. J.
    Berg, Anna
    Wik, Elisabeth
    Birkeland, Even
    Krakstad, Camilla
    Kusonmano, Kanthida
    Petersen, Kjell
    Kalland, Karl H.
    Oyan, Anne M.
    Akslen, Lars A.
    Trovik, Jone
    Salvesen, Helga B.
    [J]. MODERN PATHOLOGY, 2013, 26 (03) : 428 - 434
12345